(Total Views: 460)
Posted On: 11/26/2025 10:26:17 PM
Post# of 158772
Enjay, thanks for doing the work and especially linking images which is is a thing I’ve not done in IH. It took me a little time to copy and paste the following from one of the images/ tables you showed.
“Single Patient Expanded Access Protocol for Patient BH Using Leronlimab for the Treatment of Triple Negative Breast Cancer“
It appears to me that EAP, Expanded Access Protocal is now Open at one of our sights. Since this require approval of or EAP request that Dr JL intimated was under way, I’m hopeful that EAP is under way for mTNBC. This is a cause for a Happy Thanksgiving if accurate.
From the Fall letter to shareholders…
“In parallel, we will be submitting an Expanded Access Protocol (“EAP”) to enable treatment for patients with second-line, or later, mTNBC, who are ineligible or otherwise unable to participate in our Phase II study. I am pleased to announce that we will be working with an individual benefactor to fund the launch of this compassionate-use program. This benefactor has also expressed interest in supporting an investigator-initiated study in patients with recurrent glioblastoma with an anticipated start date in 2026.”
https://www.cytodyn.com/investors/news-events...areholders
My question is this.
Do you know what “…for Patient BH…” means?
“Single Patient Expanded Access Protocol for Patient BH Using Leronlimab for the Treatment of Triple Negative Breast Cancer“
EAP status seems Open. But I’m not sure what Patient BH means. Ugh…professional jargon?
“Single Patient Expanded Access Protocol for Patient BH Using Leronlimab for the Treatment of Triple Negative Breast Cancer“
It appears to me that EAP, Expanded Access Protocal is now Open at one of our sights. Since this require approval of or EAP request that Dr JL intimated was under way, I’m hopeful that EAP is under way for mTNBC. This is a cause for a Happy Thanksgiving if accurate.
From the Fall letter to shareholders…
“In parallel, we will be submitting an Expanded Access Protocol (“EAP”) to enable treatment for patients with second-line, or later, mTNBC, who are ineligible or otherwise unable to participate in our Phase II study. I am pleased to announce that we will be working with an individual benefactor to fund the launch of this compassionate-use program. This benefactor has also expressed interest in supporting an investigator-initiated study in patients with recurrent glioblastoma with an anticipated start date in 2026.”
https://www.cytodyn.com/investors/news-events...areholders
My question is this.
Do you know what “…for Patient BH…” means?
“Single Patient Expanded Access Protocol for Patient BH Using Leronlimab for the Treatment of Triple Negative Breast Cancer“
EAP status seems Open. But I’m not sure what Patient BH means. Ugh…professional jargon?
(2)
(0)
